Phase 1b Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Repeated Doses of DB-020 in Patients Receiving Cisplatin

Brief Summary

Type:
Head and Neck Cancers

Study Type:
Prevention

Phase:
I

ClinicalTrials.gov Identifier:
NCT04262336

Study #:
STUDY00144924

Start Date:
Feb 25, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04262336

View Complete Trial Details & Eligibility at ClinicalTrials.gov